Scott E Delacroix Jr M.D.

2.4K posts

Scott E Delacroix Jr M.D. banner
Scott E Delacroix Jr M.D.

Scott E Delacroix Jr M.D.

@UroCancer

Medical Director Urologic Oncology/GU Cancers. Mary Bird Perkins Cancer Center. Metairie, Louisiana. Bladder and Prostate Cancer subspecialty.

New Orleans Katılım Nisan 2014
971 Takip Edilen1.9K Takipçiler
Scott E Delacroix Jr M.D. retweetledi
Julian Chavarriaga
Julian Chavarriaga@chavarriagaj·
#EAU26 The future of MIBC may be decision-guided, not surgery-driven. Dr Zlotta @PMResearch_UH: 🔹 pCR rates reach ~57% after modern NAT 🔹 But predicting true pT0 or cCR remains imperfect (ctDNA/MRI sensitivity ~46–59%) 🔹 Up to 1 in 4 apparent cCRs still harbor residual MIBC 💡 The field is moving toward biomarker-guided bladder preservation — but RC/TMT are not going away yet 👇 @uroweb @UroToday
Julian Chavarriaga tweet media
English
1
22
49
2.8K
Scott E Delacroix Jr M.D. retweetledi
Tom Powles
Tom Powles@tompowles1·
Discussion #EAU26 about the future of cystectomy neoadjuvant treatment and radiotherapy in muscle invasive bladder cancer. Things are changing rapidly. With pCR rates >50% for EVP many patients will want to keep their bladders. An era of ‘EVP 1st and ask questions later’ maybe a reality soon. Generation of EVP bladder sparing data is a priority. @Uroweb @EUplatinum
Tom Powles tweet media
English
3
45
122
14.5K
Scott E Delacroix Jr M.D. retweetledi
Matt Cooperberg
Matt Cooperberg@dr_coops·
Prof Hugosson: Göteborg trial with 30 year outcomes! NND falls to -6-, with greatest benefit for men 50-59 at randomization. Despite no image guidance, high overdx, and suboptimal tx. Best evidence we have re: the evidence for #prostatecancer screening. Get tested! #eau26 @uroweb
Matt Cooperberg tweet mediaMatt Cooperberg tweet mediaMatt Cooperberg tweet mediaMatt Cooperberg tweet media
English
0
39
98
6K
Scott E Delacroix Jr M.D. retweetledi
Archaeo - Histories
Archaeo - Histories@archeohistories·
In 1951, a restaurant in New Orleans created a dessert on a dare and accidentally invented one of the most dramatic dishes in American culinary history. The city was flooded with bananas. New Orleans was the single largest port of entry for banana imports from Central and South America in the entire United States, and Owen Brennan, the Irish-American owner of Brennan's Restaurant on Royal Street, wanted a dish that put the fruit at the center of the table. He handed the challenge to his chef Paul Blangé and his younger sister Ella, and told them to build something worthy of the restaurant. What came out of that kitchen was Bananas Foster, named after Richard Foster, chairman of the New Orleans Crime Commission and one of Brennan's closest friends and most loyal regulars. The dish is simple. Brown sugar, butter, cinnamon, banana liqueur, and fresh bananas cooked in a copper pan until the sauce is deep and glossy and the bananas are just soft enough to give. Then the rum goes in, the pan tilts toward the flame, and the whole table goes quiet for thirty seconds while blue fire burns off the alcohol and leaves behind something that smells like the best version of caramel you have ever encountered. Then it goes over cold vanilla ice cream and the whole thing is done in under ten minutes. Seventy-five years later Brennan's still flames 35,000 pounds of bananas every single year for this one dessert. Seventy-five percent of all desserts ordered at the restaurant are still Bananas Foster. It has been on the menu every single day since 1951 and it has never needed to change because it was right the first time. © Eats History #archaeohistories
Archaeo - Histories tweet media
English
74
525
4.1K
210.2K
Scott E Delacroix Jr M.D. retweetledi
Dudes Posting Their W’s
Dudes Posting Their W’s@DudespostingWs·
LSU was down 3-0 in the bottom of the 9th and this happened…
English
57
412
5.2K
247.1K
Scott E Delacroix Jr M.D. retweetledi
Andrea Apolo, M.D.
Andrea Apolo, M.D.@apolo_andrea·
@SvatekRob presents the ⭐️ SUPER important LBA629 SWOG1602 Phase3 study of different BCG stains plus BCG intradermal priming in NMIBC showing that a different BCG Tokyo 172 was not inferior to TICE. Priming did not improve recurrence @ASCO #GU26 #BladderCancer
Andrea Apolo, M.D. tweet mediaAndrea Apolo, M.D. tweet mediaAndrea Apolo, M.D. tweet mediaAndrea Apolo, M.D. tweet media
English
0
14
29
3.3K
Scott E Delacroix Jr M.D. retweetledi
Dutch Rojas
Dutch Rojas@DutchRojas·
A nonprofit hospital that reported a $201 million operating loss and laid off 650 workers just bought naming rights to the Philadelphia Eagles’ practice facility.
English
159
1.7K
3.6K
199.4K
Scott E Delacroix Jr M.D. retweetledi
Ashish M. Kamat, MD, MBBS
Ashish M. Kamat, MD, MBBS@UroDocAsh·
It’s disappointing to me that TURBT continues to be dismissed as a “low-priority” procedure in so many training programs. This single step defines the entire course for a bladder cancer patient. Accurate diagnosis, precise staging, and the choice of therapy all hinge on a high quality TURBT. And the “advanced genomic analysis and molecular profiling” these same programs love to promote? It all begins with adequate, high-quality tissue obtained through a TURBT. Yet incomplete resections leave behind residual tumor in up to 78% of cases at restaging, leading to higher recurrence rates and unnecessary progression. If we are serious about improving outcomes in NMIBC - and even MIBC - we must treat TURBT with the respect it deserves: structured, deliberate training curricula, hands-on attending involvement, and real performance metrics. This is why the @IBCG_BladderCA will make this one of the focus topics of our retreat this year, #IBCG26 @UrogerliMD @JoshMeeks @bbmdmsk @siadaneshmand @RobertoContieri @paolo_gontero @ParamMariappan @joanfundi @jteoh_hk @spsutkaMD @WorldBladderCan @BladderCancerUS @drgaganprakash @SUO_YUO @veerukasi
English
10
25
140
21.5K
Scott E Delacroix Jr M.D. retweetledi
Playteaux
Playteaux@Playteaux1·
When you think you’re the coolest float in the parade until this guy shows up.
English
18
136
1.1K
24.5K
Scott E Delacroix Jr M.D. retweetledi
Baseball Unstitched
Baseball Unstitched@BaseUnstitched·
Nothing I love more in college baseball than a guy pumping 99 up eleven and getting stoked about a K College baseball is baseball in its purest form
English
8
44
2.4K
128.6K
Scott E Delacroix Jr M.D. retweetledi
Marco
Marco@marcorasi1960·
Royal and Bourbon between Esplanade and Canal, New Orleans
Marco tweet media
English
25
326
2.3K
51.3K
Scott E Delacroix Jr M.D. retweetledi
Zack Fradella
Zack Fradella@ZackFradellaWx·
A 1,000-pound Great White Shark has been pinged off our coast. The only explanation for why she is here, Mardi Gras. Here is the latest spaghetti plot of her travels. 🦈🦈🦈 #nola #mardigras
Zack Fradella tweet media
English
14
48
390
26.4K
Scott E Delacroix Jr M.D. retweetledi
Anthony DiGiorgio, DO, MHA
Anthony DiGiorgio, DO, MHA@DrDiGiorgio·
The public should be far angrier about facility fees than it is. Picture two clinics. One is an independent physician practice. The other is the exact same type of clinic, same doctors, same rooms, same services, but owned by a large hospital system. That second clinic is classified as a hospital outpatient department. Nothing about the care is different. But the prices a "hospital outpatient department" gets to charge the government are multiple times higher than the independent clinic. Routine office visits, imaging, echocardiograms, in office procedures all get marked up simply because a hospital’s name is on the door. The independent doctor gets paid one rate. The hospital owned clinic gets paid more for doing the exact same thing. That extra money lets the hospital pay higher staff salaries, outbid independents for equipment, spend more on marketing, and layer on amenities that have nothing to do with care. The independent physician is now competing against a system that is legally allowed to charge more for identical services. Patients are mostly blind to this. They are not told they are walking into a higher priced clinic. They do not see the facility fee until the bill shows up. And then the patients are screwed again once enough independent practices are driven out of business. Patients lose the option of seeing a lower cost physician altogether. They are forced into hospital owned clinics that charge more and often deliver a worse experience. This is not an accident. Medicare explicitly wrote these payment rules into its fee schedules. Private insurers largely follow Medicare’s lead, so the distortion spreads across the entire system. It's almost as if the system is designed to elminate independent physician practice...
Anthony DiGiorgio, DO, MHA tweet media
Neil Floch MD@NeilFlochMD

The one point that the general public must understand is that the cost of medicine, the rise of hospitals systems, and the fall of private practice has occurred largely because government has allowed hospital systems to be paid a “facility fee” that independent physicians cannot collect. pgpf.org/article/what-i…

English
35
167
458
26.1K
Scott E Delacroix Jr M.D. retweetledi
Kent Mouw
Kent Mouw@mouwlab·
Happy to share new work from our team now available online @CCR_AACR. We profiled plasma ctDNA dynamics in patients with muscle-invasive bladder cancer (MIBC) treated with bladder-sparing trimodality therapy (TMT)... doi.org/10.1158/1078-0…
English
5
14
43
2.8K
Scott E Delacroix Jr M.D. retweetledi
Kent Mouw
Kent Mouw@mouwlab·
Our take-home finding is that ctDNA detectability was strongly correlated with metastatic - but not local - disease recurrence. A big thanks to patients, families, research teams, colleagues, and funding sources who made this work possible!
Kent Mouw tweet mediaKent Mouw tweet media
English
3
12
45
8.2K
Scott E Delacroix Jr M.D. retweetledi
Dr. Jason Efstathiou
Dr. Jason Efstathiou@drjefstathiou·
Huge shout-out to @DrPaulNguyen for his outstanding leadership of the @NRGOnc GU group 👏! Deep thanks to @sartor_oliver for 13 years of extraordinary service as our Medical Oncology Chair — and a warm welcome to @DrRanaMcKay as she steps into the role! And always in our hearts, Dr. Felix Feng — whose visionary leadership shaped our group and whose legacy continues to be realized. Please consider supporting the ACS–ASTRO Felix Feng, MD Clinician Scientist Development Grant Award in his honor: ow.ly/URhu50XujJ6 @snseyedinMD @jmmrad @DrHowardSandler @NehaVapiwala @DrPaulNguyen @RonaldChenMD @MaryFengMD @ChadTangMD @KHoffmanMD @BrianBaumannMD @CaPSurvivorship @EdwinPosadasMD @MiyamotoDavid @AbhiAsolanki @bridget_koontz @MoningiShalini @HimanshuNagarMD @UroCancer @DrSpratticus @Katie_Spina @TylerSbrt @sophia_kamran @tranpt21 @aleberlin2 @a_dalpra @ndesai2005 @SeanSachdevMD @MassGenBrigham @NRGonc @AmericanCancer @ASTRO_org #NRG2026 #GUOnc #Leadership #Legacy #TeamScience
Dr. Jason Efstathiou tweet mediaDr. Jason Efstathiou tweet mediaDr. Jason Efstathiou tweet mediaDr. Jason Efstathiou tweet media
Dr. Jason Efstathiou@drjefstathiou

Great to reconnect with so many motivated clinical trialists, colleagues, and the #GU family at the @NRGOnc Winter Meeting #NRG2026! 2025 was a big year for NRG GU with landmark trials presented at ASTRO in plenary and clinical trials sessions (GU005, RTOG 0924, GU006) and two major bladder trials that were launched: 🔹 NRG GU014 PARRC 💉 — RT+IO vs chemoRT in NMIBC 🔹 NRG GU015 ARCHER 🏹 — 20 vs 5 (adaptive) fractions chemoRT in MIBC Lots more to come in 2026! Grateful to the PIs and study teams—and especially to the patients and families who make NRG trials possible. @snseyedinMD @jmmrad @DrHowardSandler @NehaVapiwala @DrPaulNguyen @RonaldChenMD @MaryFengMD @ChadTangMD @KHoffmanMD @BrianBaumannMD @CaPsurvivorship @EdwinPosadasMD @MiyamotoDavid @abhiAsolanki @bridget_koontz @MoningiShalini @HimanshuNagarMD @UroCancer @DrSpratticus @Katie_Spina @TylerSbrt @sophia_kamran @tranpt21 @aleberlin2 @a_dalpra @ndesai2005 @SeanSachdevMD @MassGenBrigham @NRGonc #NRGOncology #RadiationOncology #GUCancer #CancerResearch #OncologyCommunity #BladderCancer #ClinicalTrials #TeamScience

English
0
4
26
1.6K